WaveMan
WaveMan · Company
SOPH · Sophia Genetics Sa
> Search tickers & screens ⌘K
LIVE
← All companies

SOPH SOPHiA GENETICS (SOPH) Insider Trading, Ownership & Congress Trades

Software & IT · Services-computer processing & data preparation · CIK 0001840706
Quote by TradingView
C-suite buying · 1Form 144 · 19
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
41
13F, latest reported quarter
Conversions, 180 days
7
Codes C/M, not in net · $380.8K priced

What the filings say about SOPH

Insiders, 180 days
-$4.1M net sold
1 buyer · 10 sellers · 31% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$2.0M
19 notices

SOPHiA GENETICS insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, SOPHiA GENETICS SA insiders sold a net $4.1M of stock across 151 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
Xu Zhenyu
Chief Scientific Officer
SELL
2026-10-14 SECtraded 2026-10-13
4,000
$28.7K
+3.2%
Context
  • 26 earlier Form 4 trades (code P or S) here by this insider (26 sales), the last on Oct 5, 2026.
  • The trade is 0.7% of the 541,493 shares held after it.
  • 8 other insiders sold within 30 days.
  • 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Scientific Officer Xu Zhenyu sold about $28.7K of SOPH under a 10b5-1 plan on Oct 13, 2026; 8 other insiders sold within 30 days and 41 funds added in the latest 13F quarter.
Camblong Jurgi
Executive Chairman
SELL
2026-10-14 SECtraded 2026-10-12
8,500
$61.7K
+3.2%
Context
  • 33 earlier Form 4 trades (code P or S) here by this insider (33 sales), the last on Oct 5, 2026.
  • The trade is 0.3% of the 3,387,150 shares held after it.
  • 8 other insiders sold within 30 days.
  • 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Chairman Camblong Jurgi sold about $61.7K of SOPH under a 10b5-1 plan on Oct 12, 2026; 8 other insiders sold within 30 days and 41 funds added in the latest 13F quarter.
Menu Philippe
Chief Medical Officer
SELL
2026-10-14 SECtraded 2026-10-12
5,000
$36.3K
+3.2%
Context
  • 23 earlier Form 4 trades (code P or S) here by this insider (23 sales), the last on Oct 5, 2026.
  • The trade is 2.6% of the 195,993 shares held after it.
  • 8 other insiders sold within 30 days.
  • 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Medical Officer Menu Philippe sold about $36.3K of SOPH under a 10b5-1 plan on Oct 12, 2026; 8 other insiders sold within 30 days and 41 funds added in the latest 13F quarter.
Verma Abhimanyu
Chief Technology Officer
SELL
2026-10-07 SECtraded 2026-10-05
5,284
$42.9K
+3.0%
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 24, 2026.
  • The trade is 3.2% of the 166,887 shares held after it.
  • 9 other insiders sold within 30 days.
  • 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Verma Abhimanyu sold about $42.9K of SOPH under a 10b5-1 plan on Oct 5, 2026; 9 other insiders sold within 30 days and 41 funds added in the latest 13F quarter.
Puylaert Kevin
Chief Sales Officer
SELL
2026-10-07 SECtraded 2026-10-05
185
$1.5K
+3.0%
Context
  • 10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Jul 6, 2026.
  • The trade is 0.1% of the 147,763 shares held after it.
  • 9 other insiders sold within 30 days.
  • 41 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Sales Officer Puylaert Kevin sold about $1.5K of SOPH on Oct 5, 2026; 9 other insiders sold within 30 days and 41 funds added in the latest 13F quarter.
151 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 146 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$4.1M over 180 days
-$2.3M over 90 days
below 57% of Software & IT
Congress
no House purchase disclosed in the last 12 months
Funds
41 funds bought in last quarter
below 66% of Software & IT
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
1.5% of the float short (float per yahoo 2026-10-27) · 1.4 days to cover · settled 2026-10-15
below 61% of Software & IT
What changed in the last 30 days
Oct 14Executive Chairman Camblong Jurgi sold $388.2K under a 10b5-1 plan (2 trades, Oct 5 to Oct 12)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 14Chief Medical Officer Menu Philippe sold $96.4K under a 10b5-1 plan (2 trades, Oct 5 to Oct 12)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 5Director JURGI CAMBLONG filed to sell $530.0K by Oct 5 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 5Officer PHILIPPE MENU filed to sell $180.7K by Oct 5 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 5Officer ZHENYU XU filed to sell $156.5K by Oct 5 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch SOPH

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+82.5%12M
-6%+35%+76%+117%2025-102025-122026-022026-042026-062026-082026-10 2026-10-05 · Camblong Jurgi sold $326.5K2026-06-30 · Camblong Jurgi sold $279.0K2026-04-14 · Camblong Jurgi sold $213.9K2026-06-26 · Camblong Jurgi sold $186.5K2026-08-07 · Camblong Jurgi sold $144.5K2026-08-04 · Camblong Jurgi sold $138.4K2026-07-21 · Camblong Jurgi sold $132.7K2026-07-20 · Camblong Jurgi sold $125.2K2026-06-30 · Camblong Jurgi sold $118.3K2026-07-06 · Camblong Jurgi sold $118.2K2026-06-29 · Camblong Jurgi sold $106.0K2026-06-26 · Camblong Jurgi sold $103.9K2026-06-05 · CARDOZA GEORGE bought $99.0K2026-07-07 · Camblong Jurgi sold $93.3K2026-08-27 · Xu Zhenyu sold $89.1K2026-04-15 · Camblong Jurgi sold $87.4K2026-10-05 · Muken Ross sold $80.0K2026-08-19 · Valente Manuela sold $79.4K2026-08-19 · Xu Zhenyu sold $79.4K2026-08-07 · Xu Zhenyu sold $74.8K2026-08-04 · Xu Zhenyu sold $69.2K2026-09-10 · Camblong Jurgi sold $65.1K2026-08-10 · Camblong Jurgi sold $64.7K2026-10-12 · Camblong Jurgi sold $61.7K2026-10-05 · Menu Philippe sold $60.1K2026-10-05 · Xu Zhenyu sold $60.1K2026-08-25 · HIBBS KATHY L sold $54.2K2026-07-06 · Muken Ross sold $51.4K2026-09-08 · HIBBS KATHY L sold $50.8K2026-10-05 · Van Well Daan sold $50.1K2026-08-07 · Xu Zhenyu sold $49.2K2026-07-10 · Camblong Jurgi sold $47.8K2026-09-11 · Van Well Daan sold $47.1K2026-08-21 · Xu Zhenyu sold $45.4K2026-06-10 · Camblong Jurgi sold $44.5K2026-08-24 · Verma Abhimanyu sold $44.0K2026-08-25 · Menu Philippe sold $43.4K2026-05-11 · Camblong Jurgi sold $43.3K2026-10-05 · Verma Abhimanyu sold $42.9K2026-08-19 · Verma Abhimanyu sold $41.0K2026-04-10 · Camblong Jurgi sold $40.1K2026-09-14 · Menu Philippe sold $39.4K2026-10-05 · GEORGE CARDOZA filed to sell $12.8K2026-10-05 · JURGI CAMBLONG filed to sell $530.0K2026-10-05 · PHILIPPE MENU filed to sell $180.7K2026-10-05 · ROSS J MUKEN filed to sell $79.4K2026-10-05 · MANUELA VALENTE filed to sell $34.2K2026-10-05 · DAAN GUIDO MARIA VAN WELL filed to sell $49.8K2026-10-05 · ZHENYU XU filed to sell $156.5K2026-09-21 · GEORGE CARDOZA filed to sell $6.3K2026-09-21 · ROSS J MUKEN filed to sell $3.5K2026-09-11 · DAAN GUIDO MARIA VAN WELL filed to sell $46.9K2026-08-27 · ZHENYU XU filed to sell $119.4K2026-08-25 · KATHY L HIBBS filed to sell $158.4K2026-08-20 · ZHENYU XU filed to sell $49.7K2026-08-19 · ZHENYU XU filed to sell $61.0K2026-08-19 · MANUELA VALENTE filed to sell $76.2K2026-08-07 · JURGI CAMBLONG filed to sell $133.8K2026-08-07 · ZHENYU XU filed to sell $147.2K2026-08-04 · JURGI CAMBLONG filed to sell $113.8K2026-08-04 · ZHENYU XU filed to sell $56.9K2026-07-21 · JURGI CAMBLONG filed to sell $234.2K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns SOPH: institutional holders (13F)

13F holdings, latest reported quarter
GENERATION INVESTMENT MANAGEMENT LLP
6,789,560 sh
$39.2M
AIGH Capital Management LLC
3,954,194 sh
$22.8M
AKRE CAPITAL MANAGEMENT LLC
3,719,140 sh
$21.5M
ROYCE & ASSOCIATES LP
3,381,736 sh
$19.5M
PRINCIPAL FINANCIAL GROUP INC
2,364,256 sh
$13.6M

Congress trades in SOPH

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

SOPH planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
GEORGE CARDOZA
Filed 2026-10-05
$12.8K
JURGI CAMBLONG
Filed 2026-10-05
$530.0K
PHILIPPE MENU
Filed 2026-10-05
$180.7K
ROSS J MUKEN
Filed 2026-10-05
$79.4K
MANUELA VALENTE
Filed 2026-10-05
$34.2K

SOPH mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
NORTH SQUARE KENNEDY MICROCAP FUND
$136.3K position · as of 2026-05-31
0.4%
SmallCap Fund
$6.1M position · as of 2026-07-31
0.3%
SmallCap Account
$554.4K position · as of 2026-06-30
0.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.1M sold by insiders over 180 days, 41 funds added last quarter, $2.0M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
TEAMMETACRWVCRMCRWDNETDDOGAPPIOTPCTYDUOLMDB

SOPH financials

Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Gross profit$52.1M$43.9M$42.9M$31.3M
Net income-$79.0M-$62.5M-$79.0M-$87.4M
SEC XBRL, fiscal years, as known on 2026-10-28

SOPH Stock Sonar score 3/7 axes

Find similar shapesCompare

SOPH ranks highest on risk and compliance (73rd percentile) and insider conviction (56th), and lowest on institutional and government (34th), among Software & IT peers.

Insider conviction
56
Inputs
  • Net Form 4 buying (codes P and S), 180d-$2.6M · 43 pct, sector of 284
  • Insider buyers, 180d1 · 69 pct, sector of 290
Institutional and government
34
Inputs
  • Funds adding, latest quarter41 · 34 pct, sector of 415
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
73
Inputs
  • Short interest, % of float+1.5% · 73 pct, sector of 528
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

SOPH filings, in plain words

Are SOPHiA GENETICS insiders buying or selling SOPH?

In the 180 days to 2026-10-28, SOPHiA GENETICS insiders were net sellers, a net $4.1M: $99.0K of purchases and $4.2M of sales reported on Form 4, by 1 buyer and 10 sellers.

Are there planned insider sales of SOPH?

Yes. 19 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $2.0M of stock; the latest, by GEORGE CARDOZA, was filed 2026-10-05.

Read the full summary

In the 180 days to 2026-10-28, SOPHiA GENETICS insiders were net sellers of SOPH, a net $4.1M across purchases and sales reported on Form 4 by 1 buyer and 10 sellers. Sales outweighed purchases more than tenfold by value. 31% of the 85 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 19 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $2.0M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies